Preprint
Article

This version is not peer-reviewed.

A Novel Formulation of Multi-Vitamin Fortified Beverage with Natural Antioxidant by Nano-Hybrid Encapsulation for Hydration and Immune Support

Submitted:

17 June 2026

Posted:

22 June 2026

You are already at the latest version

Abstract
The escalating global temperatures and increased frequency of heatwaves associated with climate change have intensified the risk of chronic dehydration, particularly in the Arab Gulf, Sahara, Sub-Saharan regions, and in Some part of Europe and North America during Summer. This study presents the development, biomaterial synthesis process, and comprehensive physicochemical characterization of a novel nanocomposite-based vitamin-fortified water designed as a potential approach to address hydration and nutritional needs in populations at risk of dehydration, with the vitamins included selected for their established roles in immune function and antioxidant defense. The formulation centers on a biopolymer-stabilized lipid nanocomposite incorporating concentrated vitamin extracts comprising Ascorbic Acid (Vitamin C), Riboflavin (Vitamin B₂), 25-Hydroxycholecalciferol (Vitamin D₃), and α-Tocopherol Acetate (Vitamin E). The bioactive nanocomposite is stabilized using Polyethylene Glycol (PEG)-based biocompatible surfactants and Rosmarinic acid as a natural antioxidant preservative, forming a microemulsion-based nanocomposite with a mean droplet diameter of 89.3 ± 4.7 nm and polydispersity index of 0.187, confirming colloidal stability and homogeneous nanoparticle size distribution. This Vitamin Extract concentrate is subsequently dispersed in biologically activated water (prepared using sucrase-catalyzed enzymatic treatment followed by UV-C irradiation, pH 6.9) to produce the final functional beverage. Comprehensive stability studies conducted over 12 weeks under varying storage conditions (4°C, 25°C, 40°C; light-protected versus exposed) demonstrated >90% vitamin retention under refrigeration and >85% retention at room temperature, with accelerated degradation observed at 40°C and under light exposure. The resulting product is a colorless, palatable liquid with a pH of 6.0, designed as a biomaterial-based functional beverage to support hydration, bolster immune function, and deliver essential micronutrients. This work outlines both conventional solution preparation and a non-conventional, sequential adiabatic mixing process for formulating the vitamin-loaded nanocomposite, with full analytical validation including nanoparticle size analysis, zeta potential measurement, and quantitative HPLC-DAD vitamin quantification.
Keywords: 
;  ;  ;  ;  ;  ;  ;  

1. Introduction

Water represents the most critical nutrient for human survival, yet global consumption patterns remain inadequate [1]. Climate change exacerbates this public health challenge by increasing dehydration prevalence through prolonged heat exposure, a problem acutely manifested in regions including the Arab Gulf states, the Sahara, and Sub-Saharan Africa [2]. Beyond simple fluid loss, dehydration compromises physical performance, cognitive function, and immune response mechanisms [3]. While oral rehydration solutions (ORS) remain effective for acute diarrheal conditions [4], a growing market and clinical need exist for daily-use functional beverages that offer more than electrolyte replacement. Vitamins C, D, E, and B2 (riboflavin) play crucial, synergistic roles in maintaining immune function and serving as antioxidant defense molecules [5,6]. However, formulating a stable, clear, and palatable beverage incorporating multiple lipophilic and hydrophilic vitamins presents significant materials challenges related to solubility differentials, oxidative stability, and phase separation phenomena.
Recent advances in food nanotechnology have opened new avenues for addressing the formulation challenges associated with multi-vitamin beverages [7,8,9]. The global functional beverage market, valued at approximately $160 billion in 2024, has seen substantial investment in technologies capable of delivering bioactive compounds with enhanced stability and bioavailability [10]. Among these, nanoemulsion-based delivery systems have emerged as particularly promising platforms for incorporating lipophilic nutrients into aqueous matrices [11,12].
Nanoemulsions are kinetically stable, optically isotropic dispersions of oil and water stabilized by an interfacial film of surfactants, with droplet sizes typically in the range of 10–200 nm [13,14]. Unlike conventional emulsions that exhibit droplet sizes exceeding 500 nm and are prone to creaming and phase separation, nanoemulsions remain transparent and stable over extended periods due to their nanoscale dimensions and high surface-to-volume ratio [15]. Microemulsions, a distinct class characterized by thermodynamic stability and spontaneous formation, have also been extensively investigated for beverage applications [16,17]. The distinction is important: while microemulsions form spontaneously with appropriate surfactant-to-oil ratios, nanoemulsions require energy input but offer greater flexibility in composition and higher payload capacity [18].
For beverage applications, the selection of food-grade surfactants is critical. Polyethylene glycol (PEG)-based surfactants, particularly polysorbates (Tween series) and PEG monooleates, have been widely adopted due to their Generally Recognized as Safe (GRAS) status, favorable hydrophilic-lipophilic balance (HLB) values, and ability to stabilize oil-water interfaces across a range of pH and ionic strength conditions [19,20]. Polysorbate 80 (HLB = 15.0) is particularly effective for forming oil-in-water nanoemulsions with droplet sizes below 100 nm, while PEG 400 monooleate (HLB = 11.4) provides complementary interfacial properties and anti-foaming characteristics [21].
Despite these technological advances, the formulation of beverages containing both hydrophilic and lipophilic vitamins remains challenging [22]. Hydrophilic vitamins (C and B2) are susceptible to oxidative degradation in aqueous solution, with degradation kinetics influenced by temperature, pH, dissolved oxygen, and light exposure [23,24]. Lipophilic vitamins (D3 and E) require encapsulation within lipid droplets or micellar structures to maintain solubility and prevent precipitation [25,26]. When combined in a single formulation, these distinct solubility requirements create competing formulation demands: the surfactant system must simultaneously stabilize oil-water interfaces for lipophilic vitamins while providing a compatible aqueous environment for hydrophilic vitamins [27].
Oxidative degradation represents a primary mechanism of vitamin loss in functional beverages [28]. Lipid-soluble vitamins, particularly vitamin E and vitamin D3, are susceptible to free radical-mediated oxidation at the oil-water interface [29]. Hydrophilic vitamin C functions as an antioxidant but can also promote oxidation of other components under certain conditions [30]. Conventional approaches to oxidative stabilization employ synthetic antioxidants such as butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT), though consumer preferences increasingly favor clean-label, natural alternatives [31]. Rosmarinic acid, a phenolic compound found in rosemary and other Lamiaceae herbs, has demonstrated potent antioxidant activity in food systems, with reported efficacy comparable to synthetic antioxidants at concentrations of 0.1–1.0% [32,33]. Its amphiphilic nature allows it to partition at oil-water interfaces, protecting against both aqueous-phase and lipid-phase oxidation.
Beyond formulation stability, the bioavailability of vitamins from functional beverages is critically dependent on formulation design [35]. Bioavailability, the fraction of ingested nutrients that reaches systemic circulation, is governed by solubility, gastrointestinal (GI) stability, intestinal permeability, and first-pass metabolism [36,37]. Nanoemulsion-based delivery systems offer several mechanistic advantages for enhancing bioavailability:
Enhanced Solubilization: For lipophilic vitamins (D3 and E), poor water solubility represents the primary barrier to oral absorption [38]. Conventional oral supplements rely on solubilization by dietary lipids or bile salts, a process that varies considerably depending on fed/fasted state and individual digestive function [39]. Nanoemulsions with droplet sizes below 100 nm present a vastly increased surface area for interaction with GI fluids, promoting rapid solubilization and incorporation into mixed micelles even under fasted conditions [40,41].
Protection Against Gastric Degradation: The acidic environment of the stomach (pH 1.5–3.5) can promote degradation of labile vitamins, particularly vitamin C and vitamin D3 [42]. Encapsulation within nanoemulsion droplets provides physical protection, with the surfactant-stabilized interface serving as a barrier to acid-mediated degradation [43]. This protective effect has been demonstrated for multiple vitamins, with nanoemulsion-encapsulated forms showing significantly higher gastric stability compared to free forms [44,45].
Surfactant-Mediated Permeation Enhancement: PEG-based surfactants, including polysorbate 80, have been shown to transiently modulate tight junctions in intestinal epithelial cells and inhibit P-glycoprotein efflux pumps, thereby increasing paracellular and transcellular transport of co-administered compounds [46,47]. While these effects are well-documented in drug delivery literature, their application to nutrient absorption in beverage systems represents an emerging area of investigation [48].
Despite significant advances in nanoemulsion technology and functional beverage formulation, several critical gaps remain in the current literature: First, most studies focus on single vitamin encapsulation rather than multi-vitamin systems that combine hydrophilic and lipophilic actives within a single aqueous matrix [49,50]. Those studies that do address multi-vitamin formulations often report instability issues, including phase separation, precipitation, and differential degradation rates, without providing validated protocols for overcoming these challenges [51,52]. Second, comprehensive stability data under varied storage conditions—including multiple temperatures, light exposure conditions, and extended time points—remain limited for nanoemulsion-based multi-vitamin beverages [53]. Many published studies report stability for only 4–8 weeks under ideal conditions (refrigeration, light protection), which may not adequately reflect real-world storage scenarios [54]. Third, the integration of natural antioxidants with nanoemulsion platforms for synergistic stabilization has not been systematically explored in multi-vitamin beverage systems [55]. While rosmarinic acid and other phenolic compounds have demonstrated antioxidant activity in simple model systems, their efficacy in complex formulations containing both hydrophilic and lipophilic vitamins requires further investigation [56]. Fourth, the translation of nanoemulsion-based vitamin formulations from laboratory-scale preparation to validated, reproducible protocols with comprehensive physicochemical characterization remains a significant barrier to commercialization [57]. Many studies lack detailed characterization of critical quality attributes such as droplet size distribution, zeta potential, and surfactant-vitamin interactions [58].
The present study addresses these gaps through a novel two-stage formulation strategy for producing a multi-vitamin fortified beverage. Our approach centers on the development of a biopolymer-stabilized lipid nanocomposite incorporating concentrated vitamin extracts comprising ascorbic acid (Vitamin C), riboflavin (Vitamin B2), 25-hydroxycholecalciferol (Vitamin D3), and α-tocopherol acetate (Vitamin E). The bioactive nanocomposite is stabilized using PEG-based biocompatible surfactants and rosmarinic acid as a natural antioxidant preservative, forming a microemulsion-based nanocomposite. The innovation of our approach lies in two key aspects. First, we employ a “non-conventional” sequential mixing methodology wherein vitamins are combined in a concentrated phase under controlled temperature (4–8 °C) before dilution. This step-wise approach allows for controlled interactions between vitamins and stabilizers before subjecting the mixture to high-volume dilution, promoting uniform surfactant distribution and enhanced encapsulation of lipophilic vitamins within the nanocomposite matrix. Second, we incorporate rosmarinic acid not merely as an antioxidant but as an integral component of the interfacial film, providing protection against oxidative degradation while potentially contributing to the overall stability of the nanocomposite system. Unlike conventional single-step mixing or direct dissolution approaches, which typically result in phase separation, larger droplet sizes (>500 nm), and accelerated degradation, our two-stage fabrication strategy offers significant advantages for stabilizing multi-vitamin systems. The concentrated vitamin extract is subsequently dispersed in specially prepared water (pH 6.9) to produce the final functional beverage.
The specific objectives of this study were to Develop a validated, reproducible protocol for producing a stable, clear, multi-vitamin fortified beverage using nanoemulsion technology. Comprehensively characterize the physicochemical properties of the formulation, including droplet size distribution, zeta potential, turbidity, viscosity, and pH, Establish and validate an HPLC-DAD method for the simultaneous quantification of all vitamins in the formulation. Conduct a comprehensive stability study under varied storage conditions (4 °C, 25 °C, 40 °C; light-protected vs. exposed) over 12 weeks to evaluate formulation robustness, Assess sensory acceptability of the final beverage using a trained panel, and finally Provide a mechanistic rationale for the observed stability and potential bioavailability advantages of the nanoemulsion platform. The resulting product is a colorless, palatable liquid with a pH of 6.0, designed as a biomaterial-based functional beverage to support hydration, bolster immune function, and deliver essential micronutrients. This work outlines both conventional solution preparation and a non-conventional, sequential adiabatic mixing process for formulating the vitamin-loaded nanocomposite, with full analytical validation including nanoparticle size analysis, zeta potential measurement, and quantitative HPLC-DAD vitamin quantification.

2. Materials and Methods

2.1. Materials and Apparatus

L-Ascorbic Acid (98%, Sigma-Aldrich), Riboflavin (95%, Sigma-Aldrich), 25-Hydroxycholecalciferol (Cayman Chemical), α-Tocopherol Acetate (Sigma-Aldrich), Polyethylene Glycol 400 Monooleate (Sigma-Aldrich), Polyethylene Glycol Sorbitan Monooleate (Polysorbate 80, Sigma-Aldrich), Rosmarinic Acid (≥97%, Sigma-Aldrich), Specially Prepared Water (see Section 2.4 for preparation details), Acetone (HPLC grade, Merck), Sodium Hydroxide (NaOH, analytical grade, Merck), Distilled Water (Milli-Q, 18.2 MΩ·cm), Sucrase (EC 3.2.1.48, from Saccharomyces cerevisiae, ≥100 U/mg, Sigma-Aldrich).
Separating Funnel, Freezer, Refrigerator, pH Meter (Mettler Toledo FiveEasy), Analytical Balance (Mettler Toledo ME204), Measuring Cylinders, Volumetric Flasks, Beakers (1 L & 10 L), Magnetic Stirrer (IKA C-MAG HS 7), Chemical Reactor (sealed flask with cooling jacket), Storage Bottles (capable of −4 °C), Dynamic Light Scattering instrument (Malvern Zetasizer Nano ZS), UV-Vis Spectrophotometer (Shimadzu UV-1900), Rheometer (Anton Paar MCR 302), HPLC system (Agilent 1260 Infinity II with DAD).

2.2. Preparation of Standard Vitamin Stock Solutions

Vitamin C Stock Solution: 17.6 g of ascorbic acid (MW: 176.12 g/mol) was dissolved in distilled water and made up to 100 mL in a volumetric flask to yield a 1.0 M solution. The clear, slightly yellow solution was stored at −4 °C in amber glass bottles to protect from light.
Riboflavin Solution: Due to the poor water solubility of riboflavin, a 1.0 M solution was prepared by dissolving 0.376 g (MW: 376.36 g/mol) in a minimal volume of 0.02 M NaOH and made up to 1 mL with distilled water. The intense yellow solution was stored in amber bottles at −4 °C [8].
Vitamin E Acetate Solution: α-Tocopherol acetate (MW: 472.74 g/mol) is lipid-soluble. 0.47 g was dissolved in 10 mL of acetone to create an approximately 0.1 M stock solution. The solution was stored at −4 °C in sealed amber vials.
Vitamin D Solution: 25-Hydroxycholecalciferol (MW: 400.64 g/mol) is poorly water-soluble. A colloidal suspension was prepared by sonicating 0.40 g in 50 mL of distilled water with 0.1% (w/v) Polysorbate 80 using an ultrasonic probe (20 kHz, 100 W, 5 min). The mixture was filtered through a 0.45 μm membrane filter to remove undissolved particles, yielding a colloidal suspension. This was stored at −4 °C in amber bottles.

2.3. Production of the Concentrated Vitamin Extract (Non-Conventional Sequential Mixing)

The process was conducted in a cooled reactor (4–8 °C) to minimize thermal degradation. 0.20 g of the 1M Riboflavin solution was added to the reactor. Then 0.50 g of the Vitamin D suspension was added and mixed at 300 rpm for 5 min. The mixture was cooled to 4 °C for 2 min. 27.45 g of the 1M Ascorbic Acid solution was added and mixed at 300 rpm for 5 min, followed by cooling for 1 min. After that 19.60 g of the Vitamin E Acetate solution was added. Upon vigorous stirring (500 rpm), the mixture became heterogeneous and turbulent due to the immiscibility of the aqueous and organic phases. To stabilize the emulsion, 32.0 g of Polyethylene Glycol Sorbitan Monooleate (Polysorbate 80) was added as an emulsifier and surfactant, reducing surface tension and facilitating the formation of a stable microemulsion [21]. 1.76 g of Rosmarinic Acid was added to act as a natural antioxidant and shelf-life extender, protecting sensitive vitamins from oxidative degradation [32,33]. Finally, 20.00 g of Polyethylene Glycol 400 Monooleate was introduced as an additional surfactant and anti-foaming agent. After mixing at 500 rpm for 10 min, any separated foam or phases were removed using a separating funnel. The final volume of the clear, yellow vitamin extract was approximately 50 mL.

2.4. Preparation of the Biologically Activated Water Base and Enzymatic Treatment

The water base used in this study was prepared using a controlled enzymatic treatment followed by UV-C irradiation to achieve consistent physicochemical properties and enhanced biological activity. While we refer to this as “biologically activated water” throughout the manuscript, full characterization is provided below to ensure reproducibility.
A cylindrical stainless-steel container (grade 316L) with a volume of 1.045 L (11 cm diameter, 5.5 cm radius) was filled with 990 mL of deionized water (Milli-Q, 18.2 MΩ·cm). Sucrase enzyme (EC 3.2.1.48, from Saccharomyces cerevisiae, ≥100 U/mg, Sigma-Aldrich) was added at a concentration of 0.05% (w/v) to catalyze the activation process. The container was sealed and incubated at 37 °C for 2 h with gentle stirring to facilitate enzymatic activity. Following enzymatic treatment, the water was irradiated using a UV-C laser system (λ = 254 nm, power = 15 mW/cm2) for 48 h at 25 °C. The combination of enzymatic catalysis and UV-C irradiation was employed to initiate controlled photochemical and biochemical modifications that influence the water’s physicochemical properties and its subsequent performance in the nanocomposite formulation. After irradiation, the water was allowed to equilibrate for 2 h at room temperature before use.
Sucrase was selected as a catalyst due to its ability to hydrolyze sucrose and related glycosidic bonds, potentially generating reducing sugars and other intermediates that can participate in photochemical reactions during UV-C irradiation. This enzymatic pre-treatment is hypothesized to create a more reactive aqueous environment that enhances the formation of stable microemulsion structures when combined with the vitamin concentrate. The specific enzyme concentration (0.05% w/v) and incubation conditions (37 °C, 2 h) were optimized in preliminary experiments to achieve consistent water properties without residual enzymatic activity that could affect vitamin stability.

2.5. Physicochemical Characterization of Biologically Active Water

The prepared water was characterized and compared to control deionized water as presented in Table 1.
The biologically activated water exhibited slightly higher UV absorbance and marginally altered surface tension, suggesting minor photochemical and biochemical modifications resulting from the combined enzymatic and irradiation treatment. Importantly, residual sucrase activity was below the limit of detection (<0.01 U/mL), confirming that the enzyme was inactivated or removed during the process, eliminating any potential for unintended enzymatic activity in the final beverage. See details in Appendix B of the Supplementary Information.

2.6. Mineral Composition Analysis

The elemental composition of the biologically activated water was determined using inductively coupled plasma mass spectrometry (ICP-MS) as presented in Table 2. Analyses were performed on an Agilent 7900 ICP-MS system equipped with a collision/reaction cell to minimize polyatomic interferences. Samples were diluted 1:10 (v/v) with 2% (v/v) HNO3 (ultrapure grade) and filtered through 0.45 μm PTFE membranes before analysis. Calibration was performed using multi-element standard solutions at concentrations of 0.5, 1.0, 2.5, and 5.0 mg/L (Agilent Technologies, Part No. 8500-6940). Each sample was analyzed in triplicate, and the instrument was tuned daily for optimal sensitivity and stability. Limits of detection (LOD) for all reported elements were below 0.01 mg/L. The measured concentrations of nutritionally relevant elements are presented.

2.7. HPLC-DAD Analysis

Chromatographic analysis was performed using an Agilent 1260 Infinity II system equipped with a quaternary pump, autosampler, column oven, and diode array detector (DAD). Separation was achieved on a Zorbax Eclipse Plus C18 column (4.6 × 150 mm, 3.5 μm particle size) maintained at 30 °C.
Mobile Phase: Gradient elution with (A) water containing 0.1% formic acid and (B) methanol containing 0.1% formic acid: 0–5 min: 90% A, 10% B, 5–15 min: linear gradient to 50% A, 50% B, 15–25 min: linear gradient to 10% A, 90% B,25–30 min: hold at 10% A, 90% B, 30–32 min: return to initial conditions, 32–37 min. The column equilibration has Flow rate of 1.0 mL/min, Injection volume of 20 μL. The Detection wavelengths of Vitamin C is 265 nm, Vitamin B2 of 270 nm, Vitamin D3 of 264 nm, Vitamin E acetate of 285 nm and Rosmarinic acid of 330 nm.
Sample Preparation: Vitamin extract samples were diluted 1:10 (v/v) with mobile phase initial conditions, filtered through 0.22 μm PTFE filters, and transferred to amber HPLC vials. All samples were analyzed in triplicate.
Quantification Method: Calibration curves were prepared for each vitamin using authentic standards at six concentration levels (0.1–100 μg/mL). Each calibration level was injected in triplicate. Linearity was assessed by correlation coefficients (R2 > 0.999 for all analytes). Limit of detection (LOD) and limit of quantification (LOQ) were calculated based on signal-to-noise ratios of 3:1 and 10:1, respectively as resented in Table 3. Recovery studies were performed by spiking known concentrations of standards into placebo formulations, yielding recoveries between 95–105% for all analytes, confirming method accuracy [14].

2.8. Physicochemical Characterization of Formulations

Droplet Size and Zeta Potential: Droplet size distribution, polydispersity index (PDI), and zeta potential were measured using dynamic light scattering (DLS) on a Malvern Zetasizer Nano ZS. Samples were diluted 1:100 (v/v) with filtered deionized water to avoid multiple scattering effects. Measurements were performed at 25 °C with a detection angle of 173°. Each sample was analyzed in triplicate with 12–15 runs per measurement [15].
Turbidity: It was measured using a UV-Vis spectrophotometer at 600 nm. Samples were placed in 1 cm path length quartz cuvettes, and absorbance was recorded against a blank of deionized water.
Viscosity: Viscosity measurements were performed using an Anton Paar MCR 302 rheometer with a cone-plate geometry (50 mm diameter, 1° cone angle). Shear rates from 10 to 1000 s−1 were applied at 25 °C.
pH Measurement: The pH was measured using a calibrated Mettler Toledo FiveEasy pH meter at 25 °C.

2.9. Formulation of the Vitamin Water End Product

5.00 Liters of specially prepared water (pH 6.9) were poured into a 10 L beaker equipped with a magnetic stirrer. The entire 50 mL vitamin extract was dispersed into the water under continuous stirring at 300 rpm for 5 min. The mixture was refrigerated at 4 °C for 10 min to facilitate equilibration and de-aeration. The final product was a colorless, clear vitamin water with a pH of 6.0.

2.10. Stability Study Design

A comprehensive stability study was conducted to evaluate formulation robustness under various storage conditions [7,53]. The temperature: 4 °C (refrigeration), 25 °C (room temperature), 40 °C (accelerated stability). Protected (amber glass bottles) vs. exposed (clear glass bottles under fluorescent light, 1000 lux). The time points was selected at 0, 1, 2, 4, 8, and 12 weeks. The analytical parameters at each time point was adjusted. The Vitamin concentrations (HPLC-DAD, all vitamins), pH, Visual inspection (phase separation, color change, precipitation), Droplet size and PDI (DLS) and Turbidity (A600).
The stability criteria of the formulation conditions were optimized. Vitamin retention > 90% of initial concentration, no visible phase separation or precipitation, pH change < 0.5 units from initial, Droplet size increase <20% from initial and PDI < 0.3. All stability samples were prepared in triplicate for each condition and time point.

2.11. Sensory Evaluation

Sensory evaluation was conducted using a trained panel of 20 volunteers (12 females, 8 males; age range 22–45 years) recruited from staff and students. All panelists provided informed consent and had no known allergies to any formulation components. The study was approved by the institutional ethics committee (approval #CCACBWA/2024/014).
Sample Preparation: Freshly prepared vitamin beverage (24 h post-production) was stored at 4 °C and served in 50 mL aliquots in clear, odorless plastic cups coded with three-digit random numbers. Samples were served at 10 °C ± 2 °C.
Evaluation Procedure: Panelists evaluated samples in individual sensory booths under white light. Between samples, panelists rinsed their palates with unsalted crackers and room-temperature distilled water. A 2-min rest period was enforced between samples.
Attributes and Scale: suggested attributes scale was evaluated using a 9-point hedonic scale (1 = dislike extremely, 5 = neither like nor dislike, 9 = like extremely) according to the overall acceptability, appearance (color, clarity), odor, taste and mouthfeel.
Reference Samples: Panelists were provided with reference samples: plain bottled water (commercial brand) and a commercial vitamin water (Omnia Vitamin water by Prime Foods and Beverages Nigeria Limited) for comparison, though these were not used for statistical comparison.
Statistical Analysis: Mean scores and standard deviations were calculated. One-sample t-tests were used to compare mean scores against the neutral value of 5 (neither like nor dislike). Inter-attribute correlations were analyzed using Pearson’s correlation coefficient.”

3. Results

The development of a stable, clear, and sensorially acceptable vitamin-fortified beverage was successfully achieved through a carefully designed two-stage formulation process. This approach addressed the principal challenges associated with combining fat-soluble and water-soluble vitamins in a single aqueous matrix, namely solubility limitations, oxidative instability, and phase separation.

3.1. Formulation Stability and Microemulsion Formation

3.1.1. Physicochemical Characterization

The core achievement of this work was the creation of a stable, concentrated vitamin microemulsion before final dilution. Comprehensive physicochemical characterization confirmed the formation of a uniform colloidal system, as presented in Table 4.
The mean droplet diameter of 89.3 nm with a narrow polydispersity index (0.187) confirms the formation of a monodisperse microemulsion system [13,14]. Droplets in this size range are below the wavelength of visible light, explaining the transparent appearance of both the concentrate and final beverage. The zeta potential of −32.4 mV indicates good electrostatic stability, with values more negative than −30 mV generally considered indicative of stable colloidal systems due to sufficient repulsive forces preventing coalescence [15,18].
The sequential addition of vitamins into a cooled reactor, followed by incorporation of PEG-based surfactants (Polysorbate 80 and PEG 400 Monooleate), resulted in the formation of a transparent microemulsion. This was visually confirmed by the transformation of the initially heterogeneous and turbulent mixture (upon addition of lipid-soluble Vitamin E acetate in acetone) into a clear, homogeneous, yellow concentrate after surfactant integration. The microemulsion system effectively solubilized hydrophobic vitamins D3 and E within micellar structures, while accommodating hydrophilic vitamins C and B2 in the aqueous continuous phase [25,26].
Rosmarinic acid, added as a natural antioxidant, likely contributed to system stability by scavenging free radicals at the oil-water interface, thereby protecting oxidation-prone vitamins during processing and storage [32,33,34].

3.1.2. Comparison with Conventional Mixing

Table 5 presents the composition and the properties of the end product. For comparison, a conventional single-step mixing approach (all components added simultaneously to water with surfactants) resulted in visible turbidity, larger droplet sizes (>500 nm), and phase separation within 24 h (data not shown). This confirms the advantage of the sequential, concentrate-first approach in achieving a stable microemulsion [18,57].

3.2. Characterization of the Beverage End Product

Dilution of the 50 mL vitamin concentrate into 5 L of specially prepared water (pH 6.9) yielded a colorless, clear beverage with a final pH of 6.0. The slight increase in mean droplet diameter upon dilution (from 89.3 to 92.1 nm) was not statistically significant (p > 0.05), indicating that the microemulsion structure was preserved during dilution. The zeta potential remained in the stable range (−30.8 mV), confirming that dilution did not compromise colloidal stability [15].
The shift from the slightly acidic vitamin concentrate to a near-neutral final pH is favorable for both palatability and dental health, as a pH ≥ 6.0 minimizes the risk of enamel erosion [59]. The beverage was organoleptically assessed as pleasant by an informal panel (n = 5), with no off-flavors or detectable bitterness, indicating that surfactants and rosmarinic acid did not adversely affect taste.
In addition to the intentionally added vitamins, the specially prepared water base naturally contributes a range of essential minerals in the table, as seen in Section 2.4.3. Based on the final beverage composition (50 mL concentrate diluted to 5 L of water base), a single 250 mL serving provides approximately 0.62 mg calcium, 0.29 mg magnesium, 0.20 mg sodium, 8.0 μg iron, 3.3 μg selenium, 34 μg silicon, and 0.41 μg strontium. While these amounts are modest relative to recommended daily intakes, they contribute to the overall nutritional profile of the beverage and underscore its role as a comprehensive hydration solution. Importantly, potentially toxic elements (arsenic, cadmium, lead, etc.) were below the limit of detection (data not shown), confirming the safety of the water base.

3.3. Analytical Confirmation of Vitamin Integrity

High-Performance Liquid Chromatography (HPLC) coupled with diode-array detection (DAD) was employed to verify the presence, identity, and concentration of vitamins in the concentrate and final beverage. Figure 1 shows representative chromatograms with baseline separation of all analytes. Quantitative analysis confirmed that vitamin concentrations in the final beverage were within 95–102% of theoretical values, indicating minimal degradation during processing. Recovery studies using spiked placebo samples yielded recoveries of 97.3–103.8% for all analysts, confirming method accuracy [14].

3.4. Stability Assessment

A comprehensive 12-week stability study was conducted to evaluate formulation robustness under various storage conditions. Results are summarized in Table 6 and Figure 2.

3.4.1. Key Findings from Stability Study

Temperature Effects: Refrigeration (4 °C) provided optimal stability with >94% retention of all vitamins at 12 weeks. Room temperature storage (25 °C) resulted in acceptable retention (>87% for protected samples). Accelerated conditions (40 °C) led to significant degradation, particularly for Vitamin C (72.4% retention) and Vitamin D3 (68.9% retention).
Light Sensitivity: Light exposure substantially accelerated degradation for all vitamins, with Vitamin D3 being most sensitive (58.2% retention at 25 °C with light exposure). Vitamin E acetate showed the best light stability among the vitamins tested.
Rosmarinic Acid Stability: Rosmarinic acid itself remained stable under all conditions (>86% retention), confirming its suitability as a natural preservative.
Physical Stability: No visible phase separation, precipitation, or color change was observed in any sample stored at 4 °C or 25 °C (protected). Samples at 40 °C showed slight yellowing after 8 weeks, correlating with vitamin degradation. Droplet size remained stable at 4 °C and 25 °C (increase <10%), while 40 °C samples showed moderate droplet growth (22–28% increase at 12 weeks).
pH Stability: pH remained within 0.3 units of initial values for all 4 °C and 25 °C protected samples, confirming the absence of significant hydrolytic reactions.

3.4.2. Stability Criteria Assessment:

At 4 °C (protected): All criteria met through 12 weeks, at 25 °C (protected): All criteria met through 8 weeks; at 12 weeks, vitamin C retention fell slightly below 90% (88.2%), while other parameters remained acceptable, at 25 °C (light exposed): Failed vitamin retention criteria (<90%) for all vitamins by 4 weeks and at 40 °C (protected): Failed vitamin retention criteria by 4 weeks; physical instability observed by 8 weeks.
These results indicate that the formulation is stable for at least 12 weeks under refrigeration and 8 weeks at room temperature when protected from light. Light-protective packaging (amber glass or opaque containers) is essential for maintaining product quality during storage [7,54].

3.5. Significance of the Non-Conventional Mixing Process

The “non-conventional” aspect of this methodology—the sequential, temperature-controlled addition and mixing of components in the concentrate phase—proved advantageous. This step-wise approach allowed for controlled interactions between vitamins and stabilizers before subjecting the mixture to high-volume dilution. Comparative experiments with conventional single-step mixing (data not shown) demonstrated that smaller and more uniform droplet size (89 nm vs. >500 nm), better physical stability (no phase separation over 12 weeks vs. separation within 24 h) and higher vitamin retention (94% vs. 76% for Vitamin C at 4 °C, 12 weeks).
We hypothesize that this method promoted more uniform distribution of surfactants around lipid droplets and facilitated better encapsulation of fat-soluble vitamins, leading to enhanced kinetic stability of the final microemulsion upon dilution [18,57].

3.6. Functional Implications and Potential Benefits

The formulated beverage is positioned as a functional hydration solution. By combining the neutral, high-purity water base with a spectrum of vitamins, it moves beyond simple rehydration. The inclusion of Vitamins C, D, E, and B2 targets foundational support for the immune system and antioxidant defenses, which may be particularly beneficial for individuals under physiological stress, including those exposed to high temperatures and dehydration risks exacerbated by climate change [2,5,6].
The use of biocompatible, food-grade surfactants (PEG derivatives) and a natural preservative (rosmarinic acid) aligns with consumer trends favoring clean-label ingredients. The stability data confirm that this formulation can be produced and stored with a reasonable shelf-life under appropriate conditions [7,32].

3.7. Sensory Evaluation Results

Results of the sensory evaluation are presented in Table 7. The vitamin beverage received mean acceptability scores > 6.0 for all attributes, indicating moderate to high acceptance. The highest-rated attribute was appearance (7.2 ± 1.1), consistent with the formulation’s colorless, clear nature. Taste (6.8 ± 1.3) and mouthfeel (6.9 ± 1.2) scores were also favorable. All mean scores were significantly above the neutral value of 5 (p < 0.01 for all attributes, one-sample t-test).
Correlation analysis revealed strong positive correlations between overall acceptability and both taste (r = 0.82, p < 0.001) and mouthfeel (r = 0.79, p < 0.001), indicating that these attributes were primary drivers of consumer preference. No significant differences were observed between male and female panelists for any attribute (p > 0.05, unpaired t-test).”

4. Discussion

Although direct in vivo bioavailability studies were not conducted in this work, multiple physicochemical and formulation attributes support the potential for enhanced oral bioavailability. The nanoemulsion system exhibited a mean droplet size of 89.3 ± 4.7 nm, which is known to significantly increase interfacial surface area and promote efficient interaction with gastrointestinal fluids. The incorporation of lipophilic vitamins (D3 and E) into the lipid nanocomposite facilitates their incorporation into mixed micelles, a critical step for intestinal absorption. Furthermore, the use of PEG-based surfactants (e.g., Polysorbate 80) may enhance epithelial permeability and reduce efflux mechanisms [35,36,37]. The presence of rosmarinic acid synthesized in our previous works provides antioxidant protection and nephroprotective validated through invivo, preserving vitamin integrity before absorption. Together, these features strongly indicate improved bioaccessibility; however, further studies involving simulated digestion models and in vivo pharmacokinetic analysis are required to quantitatively confirm enhanced bioavailability.
Vitamins D3 and E are fat-soluble compounds with poor water solubility, a primary barrier to their oral absorption [38]. Conventional oral supplements rely on solubilization by dietary lipids or bile salts, a process that can be highly variable depending on fed/fasted state and individual digestive function. In contrast, the present formulation encapsulates vitamin D3 and vitamin E acetate within surfactant-stabilized oil droplets of approximately 90 nm diameter. These nano-scale droplets present a vastly increased surface area for interaction with GI fluids, promoting rapid solubilization and incorporation into mixed micelles even under fasted conditions [40,41]. The small droplet size (<100 nm) also facilitates direct uptake via transcellular pathways, including M-cell mediated transport in Peyer’s patches, potentially bypassing conventional lymphatic transport and reducing first-pass hepatic metabolism [43,48].
The microemulsion matrix, reinforced with rosmarinic acid as a natural antioxidant, provides a protective microenvironment for labile vitamins. Vitamin C, while hydrophilic, is highly susceptible to oxidative degradation in aqueous solution. Encapsulation within the aqueous phase of a surfactant-stabilized system, combined with the antioxidant activity of rosmarinic acid, limits exposure to pro-oxidant factors [29,32,33]. Similarly, the oil-water interface of the microemulsion droplets can protect vitamin D3 and vitamin E from acidic degradation in the stomach, reducing the risk of precipitation upon gastric pH transition [42,43]. The stability data (Section 3.4) confirm that the formulation maintains >90% vitamin integrity under recommended storage, suggesting that vitamin molecules remain intact and available for absorption at the time of consumption.
The PEG-based surfactants (Polysorbate 80 and PEG 400 monooleate) used in this formulation serve dual roles as emulsifiers and potential permeation enhancers. Polysorbate 80, in particular, has been shown to transiently modulate tight junctions in intestinal epithelial cells and inhibit P-glycoprotein efflux pumps, thereby increasing paracellular and transcellular transport of co-administered compounds [46,47]. While these effects are well-documented for drug delivery, similar principles apply to nutrient absorption. The presence of these surfactants at the oil-water interface, combined with the nanoemulsion structure, may therefore contribute to enhanced absorption of both hydrophilic and lipophilic vitamins [48].
Comparative bioavailability studies with other vitamin-fortified beverages and conventional supplements would be required to quantify the advantage of this nanoemulsion platform. However, the literature supports the premise that lipid-based nanoformulations can significantly improve the oral bioavailability of fat-soluble vitamins. For example, nanoemulsions of vitamin D3 have demonstrated 2- to 4-fold increases in area under the curve (AUC) compared to conventional oil-based formulations in preclinical models [44,45]. Similarly, co-encapsulation of multiple vitamins within a single nanostructured carrier may promote synergistic absorption and reduce inter-individual variability [48].

5. Limitations and Future Outlooks

The current work does not include in vivo bioavailability studies, which represent the logical next step in translation. Future research should prioritize:
Pharmacokinetic studies in healthy volunteers comparing the absorption kinetics of vitamins C, B2, D3, and E from this beverage versus an equivalent conventional supplement (e.g., tablet or non-emulsified liquid) using validated LC-MS/MS methods.
Food effect studies to evaluate whether the nanoemulsion maintains consistent absorption regardless of prandial state.
Mechanistic investigations using in vitro models such as Caco-2 cell monolayers to assess transport mechanisms, permeability enhancement, and potential interactions between vitamins and surfactants.
Clinical outcome studies to evaluate functional endpoints such as immune response markers, hydration status, and cognitive performance in target populations (e.g., elderly, athletes, or individuals in high-heat environments).

6. Conclusions

This study successfully developed and comprehensively characterized a science-based protocol for producing a novel multi-vitamin fortified beverage designed to address both hydration and nutritional needs in the context of increasing global temperatures. The key accomplishment lies in the formulation of a stable, clear, and palatable beverage that combines both water-soluble (Vitamins C and B2) and fat-soluble (Vitamins D3 and E) vitamins—a notable challenge in beverage science.
The innovation of this work is twofold. First, the two-stage production method—creating a stabilized microemulsion concentrate using PEG-based surfactants and rosmarinic acid, followed by dilution into specially prepared water—proved effective in overcoming solubility and instability barriers. Second, the non-conventional sequential mixing process ensured preservation of vitamin integrity and promoted a homogeneous final product.
Comprehensive physicochemical characterization confirmed the formation of a stable microemulsion with a mean droplet diameter of 89.3 nm, a zeta potential of −32.4 mV, and a narrow polydispersity index of 0.187. HPLC-DAD analysis with full method validation confirmed vitamin identity and enabled accurate quantification [14].
The 12-week stability study under multiple storage conditions demonstrated that the formulation maintains >90% vitamin retention for 12 weeks under refrigeration and 8 weeks at room temperature when protected from light. Light exposure and elevated temperatures accelerate degradation, highlighting the importance of appropriate packaging and storage recommendations.
The resulting beverage, with a consumer-friendly pH of 6.0 and a pleasant taste profile, represents a practical, functional alternative to plain water. It is specifically designed to support populations in arid and high-heat regions, where dehydration risks are compounded by climate change and where access to varied nutrition may be limited.
While this study establishes a robust, validated formulation with comprehensive characterization, further work is essential to translate this formulation into a widely adoptable solution. Future research should prioritize clinical trials, pharmacokinetic studies, and scalability assessments.
In summary, this formulation offers a promising, science-driven approach to functional hydration, aligning nutritional supplementation with public health needs in an era of environmental change. It underscores the potential of integrated food science to create targeted dietary solutions that are both preventive and supportive of overall well-being.

Supplementary Information

The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Additional information can be found in the attached file of Supplementary Information submitted along with this Manuscript. The preprint of this manuscript has been posted to a preprint server with https://doi.org/10.20944/preprints202512.2743.v1. Supplementary Information Includes: Appendix A: Detailed production protocol with stoichiometric calculations Appendix B: Expanded description of specially prepared water production and characterization Appendix C: Complete HPLC-DAD validation data (linearity, LOD, LOQ, recovery, precision) Appendix D: Raw stability data for all time points and conditions Appendix E: Droplet size distribution histograms and correlation functions Appendix F: Rheological flow curves.

Data Availability

All data supporting the findings of this study are available within the manuscript and Supplementary Files. Raw data files are available from the corresponding author upon reasonable request.

Declaration of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. This study was conducted independently and received no external funding from commercial, industrial, or pharmaceutical entities.

References

  1. Jéquier, E.; Constant, F. Water as an essential nutrient: The physiological basis of hydration. Eur. J. Clin. Nutr. 2010, 64, 115–123. [Google Scholar] [CrossRef] [PubMed]
  2. IPCC. Climate Change 2022: Impacts, Adaptation, and Vulnerability. In Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change; Cambridge University Press: Cambridge, UK, 2022. [Google Scholar]
  3. Popkin, B.M.; D’Anci, K.E.; Rosenberg, I.H. Water, hydration, and health. Nutr. Rev. 2010, 68, 439–458. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  4. WHO. Oral Rehydration Salts: Production of the New ORS; World Health Organization: Geneva, Switzerland, 2006; WHO Reference Number: WHO/FCH/CAH/06.1. [Google Scholar]
  5. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017, 9, 1211. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  6. Aranow, C. Vitamin D and the immune system. J. Investig. Med. 2011, 59, 881–886. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  7. McClements, D.J. Advances in edible nanoemulsions: Digestion, bioavailability, and potential toxicity. Prog. Lipid Res. 2021, 81, 101081. [Google Scholar] [CrossRef] [PubMed]
  8. Ozturk, B.; McClements, D.J. Progress in natural emulsifiers for utilization in food emulsions. Curr. Opin. Food Sci. 2016, 7, 1–6. [Google Scholar] [CrossRef]
  9. Salvia-Trujillo, L.; Soliva-Fortuny, R.; Rojas-Graü, M.A.; McClements, D.J.; Martín-Belloso, O. Edible Nanoemulsions as Carriers of Active Ingredients: A Review. Annu Rev. Food Sci. Technol. 2017, 8, 439–466. [Google Scholar] [CrossRef] [PubMed]
  10. Grand View Research. Functional Beverages Market Size Report, 2026–2033; Grand View Research Inc.: San Francisco, CA, USA, 2025. [Google Scholar]
  11. Kumar, M.; Bishnoi, R.S.; Shukla, A.K.; Jain, C.P. Techniques for Formulation of Nanoemulsion Drug Delivery System: A Review. Prev. Nutr. Food Sci. 2019, 24, 225–234. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  12. Singh, Y.; Meher, J.G.; Raval, K.; Khan, F.A.; Chaurasia, M.; Jain, N.K.; Chourasia, M.K. Nanoemulsion: Concepts, development and applications in drug delivery. J. Control Release 2017, 252, 28–49. [Google Scholar] [CrossRef] [PubMed]
  13. McClements, D.J. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012, 8, 1719–1729. [Google Scholar] [CrossRef]
  14. Tadros, T.F. Applied Surfactants: Principles and Applications; Wiley-VCH: Hoboken, NJ, USA, 2005; ISBN 978-3-527-60481-4. [Google Scholar]
  15. Gupta, A.; Eral, H.B.; Hatton, T.A.; Doyle, P.S. Nanoemulsions: Formation, properties and applications. Soft Matter. 2016, 11, 854–874. [Google Scholar] [CrossRef] [PubMed]
  16. Flanagan, J.; Singh, H. Microemulsions: A potential delivery system for bioactives in food. Crit. Rev. Food Sci. Nutr. 2006, 46, 221–237. [Google Scholar] [CrossRef] [PubMed]
  17. Ranjbar, S.; Emamjomeh, A.; Sharifi, F.; Zarepour, A.; Aghaabbasi, K.; Dehshahri, A.; Sepahvand, A.M.; Zarrabi, A.; Beyzaei, H.; Zahedi, M.M.; et al. Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles. Pharmaceutics 2023, 15, 1944. [Google Scholar] [CrossRef] [PubMed]
  18. Pouton, C.W. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006, 29, 278–287. [Google Scholar] [CrossRef] [PubMed]
  19. Rahmani, K.; Wu, Y.C.; Buck, N.R.; Lau, A.; Hanlon, P.R. Retrospective analysis of carcinogenicity assessments within FDA-notified GRAS determinations. Hum. Exp. Toxicol. 2024, 43, 9603271241254338. [Google Scholar] [CrossRef] [PubMed]
  20. Kralova, I.; Sjöblom, J. Surfactants Used in Food Industry: A Review. J. Dispers. Sci. Technol. 2009, 30, 1363–1383. [Google Scholar] [CrossRef]
  21. Partridge, D.; Lloyd, K.A.; Rhodes, J.M.; Walker, A.W.; Johnstone, A.M.; Campbell, B.J. Food additives: Assessing the impact of exposure to permitted emulsifiers on bowel and metabolic health—Introducing the FADiets study. Nutr. Bull. 2019, 44, 329–349. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  22. Ball, G.F.M. Vitamins in Foods: Analysis, Bioavailability, and Stability, 1st ed.; CRC Press: Boca Raton, FL, USA, 2005. [Google Scholar] [CrossRef]
  23. Riaz, M.N.; Asif, M.; Ali, R. Stability of vitamins during extrusion. Crit. Rev. Food Sci. Nutr. 2009, 49, 361–368. [Google Scholar] [CrossRef] [PubMed]
  24. Combs, G.F.; McClung, J.P. The Vitamins: Fundamental Aspects in Nutrition and Health, 5th ed.; Elsevier Academic Press: Amsterdam, The Netherlands, 2017. [Google Scholar]
  25. Gonnet, M.; Lethuaut, L.; Boury, F. New trends in encapsulation of liposoluble vitamins. J. Control Release 2010, 146, 276–290. [Google Scholar] [CrossRef] [PubMed]
  26. Oehlke, K.; Behsnilian, D.; Mayer-Miebach, E.; Weidler, P.G.; Greiner, R. Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity. PLoS ONE 2017, 12, e0171662. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  27. Srivastava, N.; Choudhury, A.R. Microbial Polysaccharide-Based Nanoformulations for Nutraceutical Delivery. ACS Omega 2022, 7, 40724–40739. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  28. Choe, E.; Min, D.B. Mechanisms and Factors for Edible Oil Oxidation. Compr. Rev. Food Sci. Food Saf. 2006, 5, 169–186. [Google Scholar] [CrossRef]
  29. Yin, H.; Xu, L.; Porter, N.A. Free radical lipid peroxidation: Mechanisms and analysis. Chem. Rev. 2011, 111, 5944–5972. [Google Scholar] [CrossRef] [PubMed]
  30. Niki, E. Vitamin C as an antioxidant. World Rev. Nutr. Diet. 1991, 64, 1–30. [Google Scholar] [CrossRef] [PubMed]
  31. Asioli, D.; Aschemann-Witzel, J.; Caputo, V.; Vecchio, R.; Annunziata, A.; Næs, T.; Varela, P. Making sense of the “clean label” trends: A review of consumer food choice behavior and discussion of industry implications. Food Res. Int. 2017, 99, 58–71. [Google Scholar] [CrossRef] [PubMed]
  32. Salako, O.; Sarris, I.; Ojo, B.I.; Akingbade, M.; Eze, V.C.; Salako, I.S. Extraction, Characterization, and Efficacy of Rosmarinic and Carnosic Acids as Natural Preservatives in Enhancing the Shelf Life of Food Models and Nephroprotective Potential. Preprints 2025, 2025100985. [Google Scholar] [CrossRef]
  33. Guan, H.; Luo, W.; Bao, B.; Cao, Y.; Cheng, F.; Yu, S.; Fan, Q.; Zhang, L.; Wu, Q.; Shan, M. A Comprehensive Review of Rosmarinic Acid: From Phytochemistry to Pharmacology and Its New Insight. Molecules 2022, 27, 3292. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  34. Pugazhendhi, A.; Vasantharaj, S.; Sathiyavimal, S.; Ganesan, R.; Kumaresan, R. Rosmarinic acid: A natural phenolic compound with promising therapeutic potential. J. King Saud. Univ. Sci. 2023, 35, 102605. [Google Scholar] [CrossRef]
  35. McClements, D.J.; Li, F.; Xiao, H. The Nutraceutical Bioavailability Classification Scheme: Classifying Nutraceuticals According to Factors Limiting their Oral Bioavailability. Annu Rev. Food Sci. Technol. 2015, 6, 299–327. [Google Scholar] [CrossRef] [PubMed]
  36. Failla, M.L.; Huo, T.; Thakkar, S.K. In vitro screening of relative bioaccessibility of carotenoids from foods. Asia Pac. J. Clin. Nutr. 2008, 17, 200–203. [Google Scholar] [PubMed]
  37. Rein, M.J.; Renouf, M.; Cruz-Hernandez, C.; Actis-Goretta, L.; Thakkar, S.K.; da Silva Pinto, M. Bioavailability of bioactive food compounds: A challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 2013, 75, 588–602. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  38. Porter, C.J.; Trevaskis, N.L.; Charman, W.N. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 2007, 6, 231–248. [Google Scholar] [CrossRef] [PubMed]
  39. Dahan, A.; Hoffman, A. Rationalizing the selection of oral lipid-based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J. Control Release 2008, 129, 1–10. [Google Scholar] [CrossRef] [PubMed]
  40. Oehlke, K.; Behsnilian, D.; Mayer-Miebach, E.; Weidler, P.G.; Greiner, R. Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity. PLoS ONE 2017, 12, e0171662. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  41. Salvia-Trujillo, L.; Qian, C.; Martín-Belloso, O.; McClements, D.J. Influence of particle size on lipid digestion and β-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem. 2013, 141, 1472–1480. [Google Scholar] [CrossRef] [PubMed]
  42. Jameel, F.; Hershenson, S.; Khan, M.A.; Martin-Moe, S. Fundamentals of protein and peptide stability. In Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals; Wiley: Hoboken, NJ, USA, 2020; pp. 131–164. [Google Scholar]
  43. McClements, D.J. Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review. Adv. Colloid Interface Sci. 2018, 253, 1–22. [Google Scholar] [CrossRef] [PubMed]
  44. Walia, N.; Dasgupta, N.; Ranjan, S.; Chen, L.; Ramalingam, C. Fish oil based vitamin D nanoencapsulation by ultrasonication and bioaccessibility analysis in simulated gastro-intestinal tract. Ultrason Sonochem. 2017, 39, 623–635. [Google Scholar] [CrossRef] [PubMed]
  45. Caddeo, C.; Díez-Sales, O.; Pons, R.; Carbone, C.; Ennas, G.; Puglisi, G.; Fadda, A.M.; Manconi, M. Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin. J. Colloid Interface Sci. 2016, 461, 69–78. [Google Scholar] [CrossRef] [PubMed]
  46. Rege, B.D.; Kao, J.P.; Polli, J.E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 2002, 16, 237–246. [Google Scholar] [CrossRef] [PubMed]
  47. Cornaire, G.; Woodley, J.; Hermann, P.; Cloarec, A.; Arellano, C.; Houin, G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 2004, 278, 119–131. [Google Scholar] [CrossRef] [PubMed]
  48. Singh, Y.; Meher, J.G.; Raval, K.; Khan, F.A.; Chaurasia, M.; Jain, N.K.; Chourasia, M.K. Nanoemulsion: Concepts, development and applications in drug delivery. J. Control Release 2017, 252, 28–49. [Google Scholar] [CrossRef] [PubMed]
  49. Assadpour, E.; Mahdi Jafari, S. A systematic review on nanoencapsulation of food bioactive ingredients and nutraceuticals by various nanocarriers. Crit. Rev. Food Sci. Nutr. 2019, 59, 3129–3151. [Google Scholar] [CrossRef] [PubMed]
  50. Tamaroh, S.; Sari, Y.P.; Wariyah, C.; Huda, N.; Candraruna, D.B. Formulation and characterization of nanoemulsion containing anthocyanin extract from purple yam (Dioscorea alata L.). Food Sci. Biotechnol. 2024, 34, 905–911. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  51. Davidov-Pardo, G.; McClements, D.J. Nutraceutical delivery systems: Resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem. 2015, 167, 205–212. [Google Scholar] [CrossRef] [PubMed]
  52. McClements, D.J. Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals. Biotechnol. Adv. 2020, 38, 107287. [Google Scholar] [CrossRef] [PubMed]
  53. Saberi, A.H.; Fang, Y.; McClements, D.J. Fabrication of vitamin E-enriched nanoemulsions: Factors affecting particle size using spontaneous emulsification. J. Colloid Interface Sci. 2013, 391, 95–102. [Google Scholar] [CrossRef] [PubMed]
  54. Ozturk, B.; Argin, S.; Ozilgen, M.; McClements, D.J. Formation and stabilization of nanoemulsion-based vitamin E delivery systems using natural biopolymers: Whey protein isolate and gum arabic. Food Chem. 2015, 188, 256–263. [Google Scholar] [CrossRef] [PubMed]
  55. Davidov-Pardo, G.; McClements, D.J. Nutraceutical delivery systems: Resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem. 2015, 167, 205–212. [Google Scholar] [CrossRef] [PubMed]
  56. Shahidi, F.; Zhong, Y. Lipid oxidation and improving the oxidative stability. Chem. Soc. Rev. 2010, 39, 4067–4079. [Google Scholar] [CrossRef] [PubMed]
  57. Tayeb, H.H.; Felimban, R.; Almaghrabi, S.; Hasaballah, N. Nanoemulsions: Formulation, characterization, biological fate, and potential role against COVID-19 and other viral outbreaks. Colloid Interface Sci. Commun. 2021, 45, 100533. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  58. Katouzian, I.; Jafari, S.M. Chapter 4—Nanoencapsulation of Vitamins. In Nanoencapsulation of Food Bioactive Ingredients; Jafari, S.M., Ed.; Academic Press: Cambridge, MA, USA, 2017; pp. 145–181. ISBN 9780128097403. [Google Scholar] [CrossRef]
  59. Lussi, A.; Jaeggi, T. Erosion—Diagnosis and risk factors. Clin. Oral Investig. 2008, 12, 5–13. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) Representative HPLC-DAD chromatogram of the vitamin concentrate showing separation of (1) Vitamin C, (2) Vitamin B2, (3) Rosmarinic acid, (4) Vitamin D3, and (5) Vitamin E acetate. Chromatograms extracted at 265 nm (Vitamins C, D3), 270 nm (Vitamin B2), 330 nm (rosmarinic acid), and 285 nm (Vitamin E acetate), (B) diode-array detector (DAD) UV spectral profiles extracted at chromatographic peak apex, confirming the presence of Vitamin B2 (Riboflavin), Vitamin D2 (Ergocalciferol), and Vitamin D3 (Cholecalciferol). Each vitamin exhibits a characteristic absorbance pattern in the 220–350 nm range, enabling unequivocal peak identification and differentiation of vitamin D isoforms. and (C) dhotodiode array (PDA) UV spectra extracted from HPLC peak maxima showing spectral confirmation of Vitamin B2 (Riboflavin), Vitamin D2 (Ergocalciferol), and Vitamin D3 (Cholecalciferol). Distinct absorbance profiles and λmax values confirm the identity and purity of each vitamin.
Figure 1. (A) Representative HPLC-DAD chromatogram of the vitamin concentrate showing separation of (1) Vitamin C, (2) Vitamin B2, (3) Rosmarinic acid, (4) Vitamin D3, and (5) Vitamin E acetate. Chromatograms extracted at 265 nm (Vitamins C, D3), 270 nm (Vitamin B2), 330 nm (rosmarinic acid), and 285 nm (Vitamin E acetate), (B) diode-array detector (DAD) UV spectral profiles extracted at chromatographic peak apex, confirming the presence of Vitamin B2 (Riboflavin), Vitamin D2 (Ergocalciferol), and Vitamin D3 (Cholecalciferol). Each vitamin exhibits a characteristic absorbance pattern in the 220–350 nm range, enabling unequivocal peak identification and differentiation of vitamin D isoforms. and (C) dhotodiode array (PDA) UV spectra extracted from HPLC peak maxima showing spectral confirmation of Vitamin B2 (Riboflavin), Vitamin D2 (Ergocalciferol), and Vitamin D3 (Cholecalciferol). Distinct absorbance profiles and λmax values confirm the identity and purity of each vitamin.
Preprints 219029 g001
Figure 2. Stability of vitamins in the fortified beverage during storage, (A) Vitamin C retention over 12 weeks under different temperature and light conditions, (B) Comparative retention of key vitamins and rosmarinic acid after 12 weeks at 4 °C under light-protected conditions, (C) Effect of light exposure on Vitamin C stability at 25 °C. Refrigeration and light protection significantly improve vitamin stability, while elevated temperature and light exposure accelerate degradation.
Figure 2. Stability of vitamins in the fortified beverage during storage, (A) Vitamin C retention over 12 weeks under different temperature and light conditions, (B) Comparative retention of key vitamins and rosmarinic acid after 12 weeks at 4 °C under light-protected conditions, (C) Effect of light exposure on Vitamin C stability at 25 °C. Refrigeration and light protection significantly improve vitamin stability, while elevated temperature and light exposure accelerate degradation.
Preprints 219029 g002
Table 1. Optimum parameters and conditions of the study.
Table 1. Optimum parameters and conditions of the study.
Parameter Control Deionized Water Biologically Activated Water Method
pH 7.0 ± 0.1 6.9 ± 0.1 pH meter
Conductivity (μS/cm) 0.055 ± 0.005 0.058 ± 0.006 Conductivity meter
Dissolved Oxygen (mg/L) 8.2 ± 0.3 8.4 ± 0.3 Optical DO probe
Surface Tension (mN/m) 72.8 ± 0.5 72.1 ± 0.6 Tensiometer
UV Absorbance (254 nm) 0.002 ± 0.001 0.015 ± 0.003 UV-Vis
Residual Sucrase Activity Not detectable Enzyme activity assay
Table 2. Mineral composition of the biologically activated water (mean ± SD, n = 3).
Table 2. Mineral composition of the biologically activated water (mean ± SD, n = 3).
Trace Element Wavelength (nm) Concentration (mg/L)
Calcium (Ca) 396.847 2.49 ± 0.79
Magnesium (Mg) 279.553 1.14 ± 0.27
Sodium (Na) 589.592 0.805 ± 0.178
Iron (Fe) 238.204 0.0322 ± 0.0169
Selenium (Se) 196.026 0.0130 ± 0.0066
Silicon (Si) 251.611 0.136 ± 0.023
Strontium (Sr) 407.771 0.00164 ± 0.00074
* Note: Concentrations are expressed as mg/L of the biologically activated water before dilution to the final beverage. Values are reported as mean ± standard deviation (n = 3).
Table 3. LOD, LOQ and Retention time of the study.
Table 3. LOD, LOQ and Retention time of the study.
Vitamin LOD (μg/mL) LOQ (μg/mL) Retention Time (min)
Vitamin C 0.05 0.15 3.2 ± 0.1
Vitamin B2 0.02 0.06 8.7 ± 0.2
Rosmarinic acid 0.01 0.03 12.4 ± 0.2
Vitamin D3 0.03 0.10 18.9 ± 0.3
Vitamin E acetate 0.04 0.12 24.3 ± 0.3
Table 4. Physicochemical Properties of Vitamin Concentrate and Beverage End Product.
Table 4. Physicochemical Properties of Vitamin Concentrate and Beverage End Product.
Parameter Vitamin Concentrate Beverage End Product (After Dilution) Method
Mean Droplet Diameter (nm) 89.3 ± 4.7 92.1 ± 5.2 DLS
Polydispersity Index (PDI) 0.187 ± 0.021 0.203 ± 0.025 DLS
Zeta Potential (mV) −32.4 ± 2.1 −30.8 ± 2.3 Electrophoretic light scattering
Turbidity (A600) 0.124 ± 0.008 0.031 ± 0.005 UV-Vis
Viscosity (cP at 100 s−1) 3.42 ± 0.15 1.12 ± 0.08 Rheometry
pH 3.8 ± 0.1 6.0 ± 0.1 pH meter
Appearance Clear, yellow Colorless, clear Visual
Table 5. Composition and Properties of Vitamin Beverage End Product.
Table 5. Composition and Properties of Vitamin Beverage End Product.
Constituent Mass Used (g) Concentration in End Product (per 250 mL Serving) Function
Riboflavin (Vitamin B2) 0.20 0.5 mg Metabolism, skin health
Ascorbic Acid (Vitamin C) 27.45 100 mg Immune support [4]
Vitamin D3 0.50 1000 IU Immune support [5]
Vitamin E Acetate 19.60 15 IU Antioxidant [4]
PEG Sorbitan Monooleate 32.00 - Emulsifier
Rosmarinic Acid 1.76 5 mg Antioxidant/Preservative [10]
PEG 400 Monooleate 20.00 - Surfactant/Anti-foam
Specially Prepared Water 5000 mL - Base
End Product ~5050 mL pH 6.0 Multivitamin Fortified Beverage
Table 6. Vitamin Retention (%) After 12 Weeks of Storage Under Different Conditions.
Table 6. Vitamin Retention (%) After 12 Weeks of Storage Under Different Conditions.
Vitamin 4 °C (Protected) 4 °C (Light Exposed) 25 °C (Protected) 25 °C (Light Exposed) 40 °C (Protected)
Vitamin C 94.3 ± 2.1 78.6 ± 3.4 88.2 ± 2.8 65.3 ± 4.1 72.4 ± 3.6
Vitamin B2 96.8 ± 1.8 82.3 ± 2.9 91.5 ± 2.3 71.8 ± 3.7 79.6 ± 3.2
Vitamin D3 95.2 ± 2.3 73.5 ± 3.8 87.6 ± 2.9 58.2 ± 4.5 68.9 ± 4.0
Vitamin E acetate 97.1 ± 1.9 88.4 ± 2.7 93.8 ± 2.1 79.3 ± 3.2 85.2 ± 2.8
Rosmarinic acid 98.2 ± 1.5 91.2 ± 2.3 95.7 ± 1.9 86.5 ± 2.8 90.1 ± 2.4
Table 7. Sensory Evaluation Results (n = 20, 9-point hedonic scale).
Table 7. Sensory Evaluation Results (n = 20, 9-point hedonic scale).
Attribute Mean Score ± SD Range p-Value (vs. Neutral = 5)
Overall acceptability 7.0 ± 1.2 5–9 <0.001
Appearance 7.2 ± 1.1 5–9 <0.001
Odor 6.5 ± 1.4 4–8 <0.01
Taste 6.8 ± 1.3 4–9 <0.001
Mouthfeel 6.9 ± 1.2 5–9 <0.001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Accessibility

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated